Possible risks if self-used incorrectly include mineral imbalance (copperzinc), skin irritation or hypersensitivity, and incorrect dosing with injectables
The Peptide Guide recommends treating reconstitution as a precision procedure, not a routine task
[13] [14] BPC-157 has been widely used both by athletes and among the general public, mainly for recovery from injury or stimulating healing in chronic conditions, [15] [12] [16] [17] but there is as yet only very limited human trial data on efficacy and only a few preliminary safety studies
The thioesterase (TE) domain is able to release the target peptide by either hydrolysis or cyclization 12,15,16 and is supposed to condense tetradepsipeptides, first to produce an octadepsipeptidyl- O -TE and then a decadepsipeptidyl- O -TE, followed by macrolactonization to form the cyclic twelve residue product cereulide 8,9
Duration of Therapy: 17 days Additional Notes: This protocol is designed to be administered up to twice per year
(Abbreviations: NDA: new drug application
